Publications | Lund University Publications

1 – 10 of 10

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Hedlund%2C+G%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Hedlund%2C+G%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2004
Mark Interleukin-10 mediates the protective effect of Linomide by reducing CXC chemokine production in endotoxin-induced liver injury
Li, Xiang ^LU ; Klintman, Daniel ^LU ; Sato, T ; Hedlund, G ; Schramm, R ; Jeppsson, Bengt ^LU and Thorlacius, Henrik ^LU (2004) In British Journal of Pharmacology 143(7). p.865-871
- Contribution to journal › Article
2003
Mark Linomide and antibody-targeted superantigen therapy abolishes formation of liver metastases in mice.
Liu, Qing ^LU ; Klintman, Daniel ^LU ; Corbascio, M ; Ekberg, Henrik ^LU ; Hedlund, G ; Forsberg, G and Thorlacius, Henrik ^LU (2003) In European Surgical Research 35(6). p.457-463
- Contribution to journal › Article
Mark Roquinimex inhibits dextran sodium sulfate-induced murine colitis
Liu, Qing ^LU ; Wang, Yusheng ^LU ; Wan, MX ; Zhang, XW ; Andersson, G ; Hedlund, G and Thorlacius, Henrik ^LU (2003) In Inflammation Research 52(2). p.64-68
- Contribution to journal › Article
Mark Fetal antigen 1 (FA1) in the adult rat adrenal gland, ovary and pituitary gland
Hedlund, G Persdotter ; Carlsson, H E ; Shieck, E ; Nilsson, I ; Lundblad, Cornelia ^LU ; Arons, S ; Iversen, A K ; Looman, C ; Jensen, H E and Hau, J (2003) In In Vivo 17(1). p.1-4
- Contribution to journal › Article
1997
Mark Prevention of superantigen induced down-regulation of T cell mediated cytotoxic activity by IL-2 in vivo. 1996 Accepted for publication in Immunology
Belfrage, Hans ^LU ; Dohlsten, M ; Hedlund, G and Kalland, T (1997) In Immunology 90(2). p.8-183
- Contribution to journal › Article
Mark Prevention of superantigen-induced tolerance in vivo by interleukin-2 treatment. 1996 Submitted
Belfrage, Hans ^LU ; Dohlsten, M ; Hedlund, G and Kalland, T (1997) In Cancer Immunology and Immunotherapy 44(2). p.77-82
- Contribution to journal › Article
1995
Mark Enhanced and prolonged efficacy of superantigen-induced cytotoxic T lymphocyte activity by interleukin-2 in vivo
Belfrage, Hans ^LU ; Dohlsten, M ; Hedlund, G and Kalland, T (1995) In Cancer Immunology and Immunotherapy 41(2). p.87-94
- Contribution to journal › Article
1994
Mark Combined activation of murine lymphocytes with staphylococcal enterotoxin and interleukin-2 results in additive cytotoxic activity
Belfrage, Hans ^LU ; Bhiladvala, Pallonji ^LU ; Hedlund, G ; Dohlsten, M and Kalland, T (1994) In Cancer Immunology and Immunotherapy 38(4). p.71-265
- Contribution to journal › Article
1989
Mark Maximal interferon-gamma production and early synthesis of interleukin-2 by CD4+ CDw29- CD45R- p80- human T lymphocytes.
Hedlund, G ; Dohlsten, M ; Sjögren, Hans Olof ^LU and Carlsson, R (1989) In Immunology 66(1). p.49-53
- Contribution to journal › Article
1988
Mark Lymphocyte subpopulations and lymphokine production in children with constitutional aplastic anemia
Dohlsten, M ; Hedlund, G ; Békássy, Albert ^LU ; Lindén, Ola ^LU ; Garwicz, Stanislaw ^LU ; Wiebe, Thomas ^LU ; Sjögren, H O and Carlsson, R (1988) In Pediatric Hematology & Oncology 5(2). p.143-151
- Contribution to journal › Article

your query:: Remove author: Hedlund, G